another three month delay on a drug that doesnt even meet OS against GMCSF. Amgen oncology wake up the drug isnt going to get approved. And this is the only egg left in you basket. Neulasta goes off patient this year. Neulasta device isnt going to help with biosimilar Granix is approved for home administration. If a diabetic can inject themselves daily insulin, people can do Granix and its alot cheaper than Neulasta and a injectable device. Medicare will not cover it.
TVEC
Aucun commentaire:
Enregistrer un commentaire